189 related articles for article (PubMed ID: 33307843)
1. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal.
Kong D; Jiang T; Liu J; Jiang X; Liu B; Lou C; Zhao B; Carroll SL; Feng G
Drug Deliv; 2020 Nov; 27(1):1729-1740. PubMed ID: 33307843
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-loaded CalliSpheres:
Duan X; Zhao G; Han X; Ren J; Li H; Chen P; Wang M; Ju S
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982781
[TBL] [Abstract][Full Text] [Related]
3. Preparation of PLGA microspheres loaded with 10-hydroxycamptothecin and arsenic trioxide and their treatment for rabbit hepatocellular carcinoma.
Wu Y; Du D; Chen J; Liu C
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):57-63. PubMed ID: 31907490
[TBL] [Abstract][Full Text] [Related]
4. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide-eluting Callispheres beads is more effective and equally tolerant compared with arsenic trioxide/lipiodol emulsion in the transcatheter arterial chemoembolization treatment for unresectable hepatocellular carcinoma patients.
Duan XH; Ju SG; Han XW; Ren JZ; Li FY; Chen PF; Wu YY; Li H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1468-1480. PubMed ID: 32096197
[TBL] [Abstract][Full Text] [Related]
6. Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy.
Huang Y; Xu Z; Wei Y; Han S; Cai X; Chen D
AAPS PharmSciTech; 2022 Apr; 23(4):111. PubMed ID: 35411416
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.
Wang HY; Zhang B; Zhou JN; Wang DX; Xu YC; Zeng Q; Jia YL; Xi JF; Nan X; He LJ; Yue W; Pei XT
Cell Death Dis; 2019 Jun; 10(6):453. PubMed ID: 31186405
[TBL] [Abstract][Full Text] [Related]
8. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X
Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794
[TBL] [Abstract][Full Text] [Related]
9. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
10. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
[TBL] [Abstract][Full Text] [Related]
11. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Jiang H; Ma Y; Chen X; Pan S; Sun B; Krissansen GW; Sun X
Cancer Sci; 2010 Apr; 101(4):975-83. PubMed ID: 20219070
[TBL] [Abstract][Full Text] [Related]
12. Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
Sun J; Cheng M; Ye T; Li B; Wei Y; Zheng H; Zheng H; Zhou M; Piao JG; Li F
Nanomedicine (Lond); 2022 Nov; 17(26):2037-2054. PubMed ID: 36789952
[TBL] [Abstract][Full Text] [Related]
13. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically.
Zhang X; Hu B; Sun YF; Huang XW; Cheng JW; Huang A; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J; Yang XR
Clin Transl Med; 2021 Feb; 11(2):e335. PubMed ID: 33634982
[TBL] [Abstract][Full Text] [Related]
15. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable poly(lactide-co-glycolide) microspheres encapsulating hydrophobic contrast agents for transarterial chemoembolization.
Jeon SI; Kim MS; Kim HJ; Kim YI; Jae HJ; Ahn CH
J Biomater Sci Polym Ed; 2022 Mar; 33(4):409-425. PubMed ID: 34613885
[TBL] [Abstract][Full Text] [Related]
18. Will Arsenic Trioxide Benefit Treatment of Solid Tumor by Nano- Encapsulation?
Fu X; Li YS; Zhao J; Yu LL; Luo RG; Liang QR; Tang Q
Mini Rev Med Chem; 2020; 20(3):239-251. PubMed ID: 31760930
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY
Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648
[TBL] [Abstract][Full Text] [Related]
20. Preparation of microspheres encapsulating sorafenib and catalase and their application in rabbit VX2 liver tumor.
Li X; Yu H; Huang Y; Chen Y; Wang J; Xu L; Zhang F; Zhuge Y; Zou X
Biomed Pharmacother; 2020 Sep; 129():110512. PubMed ID: 32768982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
